E
REGENXBIO Inc. RGNX
$6.72 $0.172.60%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -51.19M -59.60M -52.99M -63.33M -62.89M
Total Depreciation and Amortization 4.02M 3.96M 4.05M 4.18M 4.34M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 3.88M 9.02M 7.48M 11.85M 8.57M
Change in Net Operating Assets 11.66M 6.07M -4.04M -8.16M 9.22M
Cash from Operations -31.62M -40.55M -45.50M -55.46M -40.76M
Capital Expenditure -1.08M -326.00K -474.00K -557.00K -1.13M
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 41.35M 50.58M 206.00K 13.74M 35.10M
Cash from Investing 40.27M 50.26M -268.00K 13.18M 33.97M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 38.00K 644.00K 192.00K 132.90M 209.00K
Repurchase of Common Stock 0.00 0.00 0.00 -910.00K 0.00
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -7.78M -11.50M -9.64M -11.26M -12.17M
Cash from Financing -7.74M -10.86M -9.45M 120.73M -11.96M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 909.00K -1.15M -55.21M 78.45M -18.75M
Weiss Ratings